Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
HIV+Aging Research Project Palm Springs (HARP-PS), Palm Springs, CA, United States.
Medicine (Baltimore). 2022 Aug 5;101(31):e29907. doi: 10.1097/MD.0000000000029907.
Since the emergency approval of several therapeutic coronavirus disease 2019 (COVID-19) vaccines in the United States, >500 million doses have been administered. However, there have been disparities in vaccine acceptability and uptake. We examined demographic, human immunodeficiency virus (HIV) disease, and psychosocial factors associated with COVID-19 vaccine acceptability in older adults (≥50 years) living with HIV in the Coachella Valley, California. Participants completed a 1-time anonymous online questionnaire assessing their demographic (i.e., age, race, education, etc), HIV disease (i.e., viral suppression, years living with HIV, acquired immunodeficiency syndrome diagnosis), psychosocial (i.e., HIV-related stigma, personal mastery, depression, etc) characteristics, and COVID-19 vaccine acceptability. Respondents were offered an electronic $20 United States dollar (USD) gift card for survey completion. Descriptive, univariable, and multivariable tests were conducted to analyze the data. Between September 2020 and February 2021, 114 surveys were completed. Eighty-six (75%) agreed/strongly agreed with the COVID-19 vaccine acceptability statement that they saw no problem with receiving a COVID-19 vaccine if one became available. Among those who agreed/strongly agreed, the mean age was 62.2 years (standard deviation = 7.20); 86% self-identified as White; 95% male; 91% with more than high school education; and 31% with annual income <$20,000 USD. Among respondents who disagreed/strongly disagreed, the mean age was 59.9 years (standard deviation = 4.85); 50% self-identified as White; 50% male; 64% with more than high school education; and 4% with annual income <$20,000 USD. In the univariable analyses, those who disagreed/strongly disagreed with the COVID-19 vaccine acceptability statement were significantly more likely to be living with HIV for fewer years, experiencing higher levels of HIV-related stigma and depression, and with lower levels of personal mastery. In the multivariable logistic regression model, self-identification as female vs male and unemployed vs employed was significantly associated with decreased COVID-19 vaccine acceptability (odds ratio = 0.09, 95% confidence interval: 0.01-0.71 and odds ratio = 0.08, 95% confidence interval: 0.01-0.70 respectively), adjusting for ethnicity, marital status, education, disability, years living with HIV, HIV-related stigma, and depression. Additional studies are needed to understand vaccine-related decision-making among older adults living with HIV. Programmatic efforts may also be necessary to disseminate accurate information/resources about COVID-19 vaccines to those with more recent HIV diagnoses, experiencing HIV-related stigma and depression, with lower levels of personal mastery, and facing socioeconomic disparities.
自美国紧急批准几种治疗 2019 年冠状病毒病(COVID-19)的疫苗以来,已接种了超过 5 亿剂疫苗。然而,疫苗的可接受性和接种率存在差异。我们研究了加利福尼亚州科切拉谷(Coachella Valley)年龄在 50 岁及以上的 HIV 感染者中,与 COVID-19 疫苗可接受性相关的人口统计学、人类免疫缺陷病毒(HIV)疾病和社会心理因素。参与者完成了一次匿名在线问卷调查,评估他们的人口统计学特征(如年龄、种族、教育程度等)、HIV 疾病(如病毒抑制、感染 HIV 的年限、获得性免疫缺陷综合征诊断)、社会心理因素(如 HIV 相关耻辱感、个人掌控感、抑郁等)和 COVID-19 疫苗可接受性。为完成调查,受访者可获得一张价值 20 美元的电子礼品卡。进行了描述性、单变量和多变量检验来分析数据。2020 年 9 月至 2021 年 2 月期间,完成了 114 项调查。86 名(75%)受访者同意/强烈同意 COVID-19 疫苗可接受性声明,表示如果有疫苗可用,他们不会有任何问题。在同意/强烈同意的受访者中,平均年龄为 62.2 岁(标准差=7.20);86%自认为是白人;95%为男性;91%接受过高中以上教育;31%年收入低于 20000 美元。在不同意/强烈不同意的受访者中,平均年龄为 59.9 岁(标准差=4.85);50%自认为是白人;50%为男性;64%接受过高中以上教育;4%年收入低于 20000 美元。在单变量分析中,不同意/强烈不同意 COVID-19 疫苗可接受性声明的人更有可能 HIV 感染年限较短、HIV 相关耻辱感和抑郁程度较高、个人掌控感较低。在多变量逻辑回归模型中,与男性相比,女性自我认同和与就业相比失业与 COVID-19 疫苗可接受性降低显著相关(比值比=0.09,95%置信区间:0.01-0.71 和比值比=0.08,95%置信区间:0.01-0.70),调整了种族、婚姻状况、教育程度、残疾、感染 HIV 的年限、HIV 相关耻辱感和抑郁程度。需要进一步研究以了解 HIV 感染者对疫苗的相关决策。可能还需要开展项目工作,向近期诊断出 HIV、面临 HIV 相关耻辱感和抑郁、个人掌控感较低以及面临社会经济差异的人群传播有关 COVID-19 疫苗的准确信息/资源。